VERAXA Biotech AG, an emerging leader in designing novel cancer therapies, and Voyager Acquisition Corp., a Cayman Islands exempted company and special purpose acquisition...
Atreo, the next generation Randomization and Trial Supply Management (RTSM) provider, has released its groundbreaking v2.0 Platform. Specifically designed in collaboration with large pharmaceutical...
Paradromics, a neurotechnology company developing the highest data-rate brain-computer interface (BCI) platform, announced the appointment of Dr. Stephen Ryu as Chief Medical Officer (CMO)....
Cellino, a biotechnology company pioneering autonomous biomanufacturing for personalized regenerative medicine, announced its expansion into the Asia-Pacific region through a strategic collaboration with Karis...
Here is Read Magazine’s Weekly Roundup of the top news from global markets. In this fast-paced world, breaking down information helps readers grasp the...
